Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LBT Innovations Limited (AU:CC5)
:CC5
Holding AU:CC5?
Track your performance easily
CC5 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.04
Previous CloseN/A
Volume1.22M
Average Volume (3M)1.51M
Market Cap
AU$31.68M
Enterprise ValueAU$24.16M
Total Cash (Recent Filing)$3.50M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.56
Next Earnings
Mar 04, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,759,825,300
10 Day Avg. Volume780,842
30 Day Avg. Volume1,509,988
Standard Deviation0.30
R-Squared0.02
Alpha-0.00104
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)4.79
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.76
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit18.22
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LBT Innovations Limited News
PremiumCompany Announcements
Clever Culture Systems Limited Cancels Expiring Securities
PremiumCompany Announcements
Clever Culture Systems Announces New Securities IssueOptions Prices
Currently, No data available
---
Ownership Overview
5.72%
Insiders
― Other Institutional Investors
94.28% Public Companies and
Individual Investors
CC5 FAQ
What was LBT Innovations Limited’s price range in the past 12 months?
LBT Innovations Limited lowest share price was AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is LBT Innovations Limited’s market cap?
LBT Innovations Limited’s market cap is AU$31.68M.
When is LBT Innovations Limited’s upcoming earnings report date?
LBT Innovations Limited’s upcoming earnings report date is Mar 04, 2025 which is in 41 days.
How were LBT Innovations Limited’s earnings last quarter?
LBT Innovations Limited released its earnings results on Aug 28, 2024. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is LBT Innovations Limited overvalued?
According to Wall Street analysts LBT Innovations Limited’s price is currently Overvalued.
Does LBT Innovations Limited pay dividends?
LBT Innovations Limited does not currently pay dividends.
What is LBT Innovations Limited’s EPS estimate?
LBT Innovations Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LBT Innovations Limited have?
LBT Innovations Limited has 1,759,825,300 shares outstanding.
What happened to LBT Innovations Limited’s price movement after its last earnings report?
LBT Innovations Limited reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -50%.
Which hedge fund is a major shareholder of LBT Innovations Limited?
Currently, no hedge funds are holding shares in AU:CC5
---
LBT Innovations Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:CC5 Sentiment 70%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.76%
12-Months-Change
Fundamentals
Return on Equity
-322.69%
Trailing 12-Months
Asset Growth
7.61%
Trailing 12-Months
Company Description
LBT Innovations Limited
LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.
---
Technical Analysis
Cyclopharm Limited
―
Race Oncology Ltd.
―
Resonance Health Ltd
―
Control Bionics Ltd.
―
Uscom Limited
―
InhaleRx Limited
―
---